Separator

TCS Launches New Suite for COVID-19 Testing and Vaccine Management

Separator
TCS Launches New Suite for COVID-19 Testing and Vaccine Management

India's largest IT services firm Tata Consultancy Services (TCS) has announced the launch of a suite of COVID-19 testing and vaccine management solutions that rationalises stages of the end-to-end testing and vaccination journeys.

The company declared that the suite of modular, easy-to-deploy solutions streamlines every stage of the end-to-end testing and vaccination, enabling more individuals to get tested and vaccinated faster and to return to normal life experiences.

TCS states there is an opportunity to provide a seamless process across the entire value chain to prevent issues that could slow down testing and vaccinations. The suite leverages AI, robotics, blockchain and Internet of Things (IoT).

All the five stages of testing and vaccination journeys will be transformed by the suite. Such as Research and manufacture, allocation, transport, storage and distribution, scheduling and administering, and monitoring and re-opening.

The suite enables an ecosystem for participants at each of these every stages to go through effortlessly and share critical information among them while conforming to privacy and consent regulations, to measure up their operations. Thus, communities will receive the required quantities of tests and vaccines accordingly.

While designing its new solution suite, TCS has outdone the example of successful retailers and other consumer-centric enterprises that it’s people-centric approach towards optimising the testing and vaccination ecosystems.

Debashis Ghosh, Business Group Head - Life Sciences, Healthcare and Public Sector, TCS states, “The pandemic is changing our world in many ways, driving stakeholder collaboration across industries that share a commitment to getting testing and vaccines to everyone."
Debashis further adds, “TCS suite of COVID-19 Testing and Vaccine Management solutions is built to enable transparency, ease of access, and equity that will collectively accelerate a return to normality.”